Viking Therapeutics (FRA:1VT) 3-Year Book Growth Rate : 1.40% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Viking Therapeutics 3-Year Book Growth Rate?

Viking Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €7.80.

During the past 12 months, Viking Therapeutics's average Book Value per Share Growth Rate was 401.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 1.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Viking Therapeutics was 114.80% per year. The lowest was -21.40% per year. And the median was 33.90% per year.

Competitive Comparison of Viking Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Viking Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viking Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viking Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Viking Therapeutics's 3-Year Book Growth Rate falls into.

Viking Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Viking Therapeutics (FRA:1VT) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Viking Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Viking Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Viking Therapeutics (FRA:1VT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viking Therapeutics Inc (FRA:1VT) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

VKTX:USA 1VT:Germany

Address

9920 Pacific Heights Boulevard, Suite 350, San Diego, CA, USA, 92121

Website

https://www.vikingtherapeutics.com

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Viking Therapeutics (FRA:1VT) Headlines

No Headlines